Lakeland Regional Medical Center

(863) 687-1100

Lakeland Regional Cancer Center
Lakeland Regional Cancer Center
Lakeland Regional Cancer Center

Print Page

Leukemia

Chronic Lymphocytic Leukemia and Small Lymphocytic Leukemia.

Clinical Trial # E1912:

  • Ibrutnib and Rituximab vs standard FCR to prolong progression free survival  of  Chronic Lympocytic Leukemia or Small Lymphocytic Leukemia.
  • Participants muse be 18-70 years of age with a performance status of 0-2.  The diagnosis of Chronic Lympocytic Leukemia or Small Lymphocytic Leukemia  must be according to NCI/WCLL or SLL according to WHO criteria.
  • Exclusions include but are not limited to:  Prior chemotherapy or monoclonal antibody therapy,  major surgery within 28 days of registration, radiation therapy < 4 weeks prior to registration, recent Myocardial Infarction or Cerebrovascula Accident.

© 2014 Lakeland Regional Medical Center